The efficacy of new generation endoscopic ultrasound-guided biopsy needles has been promising in recent years. Yet, comparing these needles’ diagnostic yield and safety to conventional needles is not well-known. Our study aims to compare the adverse events of endoscopic ultrasound-guided tissue acquisition (EUS-TA) with different types of needles, including FNA needles, FNB needles with a Franseen tip and FNB needles with a reverse bevel. Furthermore, we will analyze the risk factors, including tumor vascularity, different needle types, and the underlying disease, which may impact the safety of the procedures. From May 2014 to December 2021, 192 consecutive EUS-TAs were performed on pancreatic and peripancreatic lesions in our hospital using different types of FNA and FNB needles. We retrospectively reviewed the data and identified the risk factors for EUS-TA-related complications. As a result, the hypervascular tumor is a significant risk factor for adverse events in our multivariate analysis, with an odds ratio of 4.96 (95% CI 1.33–18.47), while liver cirrhosis is one of the risk factors for adverse events during EUS-TA, with an odds ratio of 5.3 (95% CI 1.1–25.6). However, the risk of adverse events did not increase using Franseen-tip needles, compared to conventional FNA or FNB needles with a reverse bevel. In conclusion, we must be more cautious in patients with liver cirrhosis and hypervascular tumors, such as pancreatic neuroendocrine tumors, when performing EUS-guided tissue acquisition.
Tumor rupture and pulmonary metastasis in patients with hepatocellular carcinoma are both associated with poor prognosis and treatment strategies are controversial.
The incidence rate of endoscopic retrograde cholangiopancreatography complication in liver transplanted patient has not been well studied. Some studies believed such patients inherit higher complication risk in ERCP procedure owing to innate structure deformity and coagulopathy condition. Our aim of this study is to evaluate the post‐ERCP complications incidence in liver transplanted patients. All liver transplant patients (deceased donor and living‐related donor) from January 2010 to December 2015 who underwent ERCP procedure alone in Changhua Christian medical center hospital were retrospective evaluated. Data regarding post‐ERCP complications, including pancreatitis, hemorrhage, perforation, and infection, are collected and analyzed. A total of 98 ERCP procedures were performed in 43 liver transplanted patients during 5‐year period. The overall incidence rate of post ERCP complications was 13.27%. The most common complication was bleeding 6.12%, followed by pancreatitis 5.10%, perforation 2.04%, and cholangitis 1.02%. Among patients with post‐ERCP hemorrhage, more than half of the patients had delay bleeding and required more than two times of endoscopic procedure. Differ from general ERCP complications, all of the perforation events were related to bile duct injury.
Background Pancreatic divisum is a common congenital anomaly that can cause chronic pancreatitis or abdominal pain. Endoscopic retrograde cholangiopancreatography with pancreas duct stenting is the treatment of choice, but sometimes it is very difficult for minor papilla cannulation. Methods We presented a difficult case in which pancreas duct stenting was performed successfully by endoscopic ultrasonography–guided rendezvous method. Results The patient was free from symptoms for several years after months of pancreas duct stenting. Conclusion While it is difficult to approach the minor papilla, endoscopic ultrasonography–guided rendezvous method is a good choice.